Select Medical Holdings (SEM) Tops Q1 EPS by 1c, Revenues In-Line; Reaffirms FY17 Guidance

Select Medical Holdings (NYSE: SEM) reported Q1 EPS of $0.21, $0.01 better than the analyst estimate of $0.20. Revenue for the quarter came in at $1.11 billion versus the consensus estimate of $1.12 billion.

GUIDANCE:

Select Medical Holdings sees FY2017 EPS of $0.78-$0.96, versus the consensus of $0.85. Select Medical Holdings sees FY2017 revenue of $4.4-4.6 billion, versus the consensus of $4.47 billion.

Business Outlook

Select Medical continues to expect for the full year of 2017 consolidated net operating revenues to be in the range of $4.4 billion to $4.6 billion and Adjusted EBITDA for the full year of 2017 to be in the range of $540.0 million to $580.0 million. Select Medical now expects fully diluted income per common share for the full year 2017 to be in the range of $0.69 to $0.87. Select Medical expects fully diluted adjusted income per common share for the full year 2017 to be in the range of $0.78 to $0.96. Fully diluted adjusted income per common share excludes the non-operating loss and loss on early retirement of debt and their related tax effects.

For earnings history and earnings-related data on Select Medical Holdings (SEM) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• Qualcomm investor day to detail data center plans Wednesday
• Worthington Industries (WOR) Misses Q4 EPS by 9c